MERRIMACK PHARMACEUTICALS IN - COM (MACK)

CUSIP: 590328100

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
63,285,552
Share change
-16,529,859
Total reported value
$78,506,603
Put/Call ratio
127%
Price per share
$1.24
Number of holders
112
Value change
-$24,561,804
Number of buys
48
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 590328100?
CUSIP 590328100 identifies MACK - MERRIMACK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q2 2017

As of 30 Jun 2017, MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,285,552 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, TIAA CREF INVESTMENT MANAGEMENT LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, NORTHERN TRUST CORP, NORGES BANK, DEUTSCHE BANK AG\, and CANNELL PETER B & CO INC. This page lists 112 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.